-
Trolox as a Redox Control in Pancreatic Organoids
2026-09-05
Trolox can do more than benchmark antioxidant capacity in pancreatic organoids. This article presents a stage-specific framework for distinguishing redox rescue from altered growth, improving oxidative injury research and high-throughput screening decisions.
-
DiI (DiIC18(3)) Plasma Membrane Probe
2026-09-05
DiI (DiIC18(3)) is a lipophilic orange fluorescent membrane dye for visualizing plasma membrane distribution, lateral membrane movement, neuronal projections, migration, and membrane-associated particles. It is water-insoluble and should not be selected for aqueous staining workflows or assays requiring intracellular organelle specificity.
-
Phosphatase Inhibitor Cocktail 3: Practical Use
2026-09-04
Phosphatase Inhibitor Cocktail 3 (100X in DMSO) helps limit dephosphorylation during extraction so phosphorylation-dependent signals can be evaluated more consistently. It is intended for prepared lysates and related sample workflows, not as an unvalidated reagent for live-cell treatment or as a replacement for protease inhibition.
-
QNZ (EVP4593) NF-κB Research Workflows
2026-09-04
QNZ (EVP4593) combines nanomolar NF-κB pathway inhibition with practical workflows for reporter, cytokine, and neuronal calcium-flux studies. This guide emphasizes assay triangulation, formulation control, and interpretation across inflammation and Huntington’s disease research.
-
Mitomycin C: Reliable Cell Assay Workflows
2026-09-03
Learn how Mitomycin C (SKU A4452) can address common variability in viability, proliferation, and apoptosis assays through disciplined concentration, solvent, exposure, and endpoint design. The article provides scenario-based guidance for cancer research, including PC3 and colon cancer models, with links to product information and relevant literature.
-
KJG and the TLR4/PI3K/AKT/FOXO1 Axis
2026-09-03
This study integrates HPLC, network pharmacology, molecular docking, and complementary animal and cell experiments to explain how Kaixin Jieyu Granule may reduce inflammation-associated depressive-like behavior. Its central contribution is linking candidate constituents, including ginsenoside Rg1 and saikosaponin d, with TLR4 suppression and PI3K/AKT/FOXO1 pathway regulation.
-
Rotigotine Hydrochloride: From Receptor to Translation
2026-09-02
A translational framework for using Rotigotine hydrochloride as a mechanistically informative dopamine D2/D3 receptor agonist across Parkinson’s disease models, cellular neuroprotection studies, formulation research, and clinically relevant exposure strategies.
-
FUS–SMN Phase Separation in Neuronal Granules
2026-09-02
Wang and Li show that asymmetric arginine dimethylation converts FUS into a stronger partner for oligomeric SMN, enabling multivalency-dependent phase separation and neuronal granule assembly. Their rescue experiments connect this molecular mechanism to axonal mRNA distribution, axon morphology, and neuronal activity, while identifying SMN valency as a disease-relevant variable in spinal muscular atrophy.
-
Cy5-UTP for RNA–LNP Assay Design
2026-09-01
Cy5-UTP enables direct fluorescent RNA detection while supporting a new assay-design perspective for RNA–lipid nanoparticle studies. Learn how Cyanine 5-uridine triphosphate can connect RNA probe synthesis, process control, and interpretation of size-dependent mRNA delivery data.
-
Nigericin Workflows for pH and Ion-Gradient Studies
2026-09-01
Nigericin gives researchers a practical way to perturb potassium/hydrogen exchange, intracellular pH, and mitochondrial ion handling in controlled cell-based assays. This guide translates that mechanism into oncology, pyroptosis-associated, and exploratory antibiotic-potentiation workflows while separating established product properties from hypotheses that require validation.
-
Cell Senescence β-Galactosidase Staining Kit: Assay Logic
2026-08-31
Learn how the Cell Senescence β-Galactosidase Staining Kit converts SA-β-Gal activity into an interpretable senescent cell detection readout. This guide connects staining design with senolytic screening, assay controls, and orthogonal validation.
-
7-Ethyl-10-hydroxycamptothecin in Assay Design
2026-08-30
7-Ethyl-10-hydroxycamptothecin (SN-38) is more than a cytotoxic benchmark. This guide presents an assay-design framework that connects topoisomerase I trapping, FUBP1/FUSE disruption, cell-cycle analysis, and apoptosis measurements in advanced colon cancer research.
-
Tamoxifen: Mechanism and Research Applications
2026-08-29
Tamoxifen is a selective estrogen receptor modulator used in breast cancer research, inducible CreER-mediated gene knockout, and mechanistic cell studies. Its tissue-selective estrogen signaling, research-grade formulation data, and assay-specific antiviral findings require model-appropriate interpretation.
-
Cyclo (-RGDfC) Workflows for Osteosarcoma Research
2026-08-29
Cyclo (-RGDfC) provides a receptor-focused way to interrogate αvβ3 integrin biology alongside viability, adhesion, migration, and targeting assays. This practical guide translates findings from a canine osteosarcoma NSAID study into better-controlled peptide experiments without confusing cytotoxicity with integrin mechanism.
-
Flumequine: Reading Topoisomerase II Responses
2026-08-28
Flumequine is a DNA topoisomerase II inhibitor best interpreted through layered, time-resolved assays rather than a single IC50. This guide connects target engagement with proliferation arrest, cell death, DNA damage, and repair decisions.